|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
|
[3]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
徐采朴. 应重视早期胃癌的内镜诊断[J]. 世界华人消化杂志, 2002, 10(4): 373-375.
|
|
[5]
|
Yao, Y., Ding, Y., Bai, Y., et al. (2020) Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer. Frontiers in Genetics, 11, Article 591515. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zheng, T.-H., Zhao, J.-L. and Guleng, B. (2015) Advances in Molecular Biomarkers for Gastric Cancer. Critical Reviews in Eukaryotic Gene Expression, 25, 299-305. [Google Scholar] [CrossRef]
|
|
[7]
|
Matsuoka, T. and Yashiro, M. (2018) Bi-omarkers of Gastric Cancer: Current Topics and Future Perspective. World Journal of Gastroenterology, 24, 2818-2832. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Shimada, H., Noie, T., Ohashi, M., Oba, K. and Takahashi, Y. (2014) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Guo, L., Wang, Q., Chen, K., Liu, H.-P. and Chen, X. (2021) Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer. Journal of Gastro-intestinal Surgery, 25, 2470-2483. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bernstein, H., Bernstein, C., Payne, C.M., Dvorakova, K. and Garewal, H. (2005) Bile Acids as Carcinogens in Human Gastrointestinal Cancers. Mutation Research, 589, 47-65. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kondo, K. (2002) Duodenogastric Reflux and Gastric Stump Carcinoma. Gastric Cancer, 5, 16-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Komichi, D., Tazuma, S., Nishioka, T., Hyogo, H. and Chayama, K. (2005) Glycochenodeoxycholate Plays a Carcinogenic Role in Immortalized Mouse Cholangiocytes via Oxidative DNA Damage. Free Radical Biology & Medicine, 39, 1418-1427. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Tatsugami, M., Ito, M., Tanaka, S., et al. (2012) Bile Acid Promotes Intestinal Metaplasia and Gastric Carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention, 21, 2101-2107. [Google Scholar] [CrossRef]
|
|
[14]
|
Chen, X.-Z., Hu, J.-K., Zhou, Z.-G., et al. (2010) Me-ta-Analysis of Effectiveness and Safety of D2 plus Para-Aortic Lymphadenectomy for Resectable Gastric Cancer. Jour-nal of the American College of Surgeons, 210, 100-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Seregni, E., Ferrari, L., Martinetti, A. and Bombardieri, E. (2001) Diagnostic and Prognostic Tumor Markers in the Gastrointestinal Tract. Seminars in Surgical Oncology, 20, 147-166. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Chen, X.-Z., Yang, K., Zhang, B., Hu, J.-K. and Zhou, C. (2011) Is Retrieval of >25 Lymph Nodes a Superior Criterion for Locally Advanced Gastric Cancer Surgery? Annals of Surgery, 254, 834-835. [Google Scholar] [CrossRef]
|
|
[17]
|
Chen, X.-Z., Yang, K., Liu, J., Chen, X.-L. and Hu, J.-K. (2011)) Neoadjuvant plus Adjuvant Chemotherapy Benefits Overall Survival of Locally Advanced Gastric Cancer. World Journal of Gastroenterology, 17, 4542-4544. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Duraker, N. and Çeli̇k, A.N. (2001) The Prognostic Significance of Preoperative Serum CA 19-9 in Patients with Resectable Gastric Carcinoma: Comparison with CEA. Journal of Surgical Oncology, 76, 266-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Louhimo, J., Kokkola, A., Alfthan, H., Stenman, U.-H. and Haglund, C. (2004) Preoperative hCGβ and CA 72-4 Are Prognostic Factors in Gastric Cancer. International Journal of Cancer, 111, 929-933. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Fu, T., Coulter, S., Yoshihara, E., et al. (2019) FXR Regulates In-testinal Cancer Stem Cell Proliferation. Cell, 176, 1098-112. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Li, T., Guo, H., Li, H., et al. (2019) MicroRNA-92a-1-5p Increases CDX2 by Targeting FOXD1 in Bile Acids-Induced Gastric Intestinal Metaplasia. Gut, 68, 1751-1763. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wu, L., Huang, P., Wang, F., et al. (2015) Relationship between Serum CA19-9 and CEA Levels and Prognosis of Pancreatic Cancer. An-nals of Translational Medicine, 3, Article No. 328.
|
|
[23]
|
Cook, J., Kennaway, E. and Kennaway, N. (1940) Production of Tumours in Mice by Deoxycholic Acid. Nature, 145, 627. [Google Scholar] [CrossRef]
|
|
[24]
|
Bernstein, H., Bernstein, C., Payne, C.M. and Dvorak, K. (2009) Bile Acids as Endogenous Etiologic Agents in Gastrointestinal Cancer. World Journal of Gastroenterology, 15, 3329-3340. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Ocvirk, S. and O’Keefe, S.J.D. (2021) Dietary Fat, Bile Acid Metabolism and Colorectal Cancer. Seminars in Cancer Biology, 73, 347-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Li, D., Zhang, J., Yao, W., et al. (2020) The Rela-tionship between Gastric Cancer, Its Precancerous Lesions and Bile Reflux: A Retrospective Study. Journal of Digestive Diseases, 21, 222-229. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Kim, D.H., Oh, S.J., Oh, C.A., et al. (2011) The Relationships between Perioperative CEA, CA 19-9, and CA 72-4 and Recurrence in Gastric Cancer Patients after Curative Radical Gastrectomy. Journal of Surgical Oncology, 104, 585-591. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Fan, B. and Xiong, B. (2011) Investigation of Serum Tumor Markers in the Diagnosis of Gastric Cancer. Hepato-Gastroenterology, 58, 239-245.
|